Late sodium current (INaL) in pancreatic β-cells

Pflugers Archiv European Journal of Physiology

Volumn 467, Issue 8, 2015, Pages 1757-1768

  Rizzetto, Riccardo ^a   Rocchetti, Marcella ^a   Sala, Luca ^a   Ronchi, Carlotta ^a   Villa, Alice ^a   Ferrandi, Mara ^b   Molinari, Isabella ^b   Bertuzzi, Federico ^c   Zaza, Antonio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Insulin secretion; Late sodium current; Pancreatic cells; Ranolazine; Sodium activated potassium current

Indexed keywords

CALCIUM ION; GLUCOSE; INSULIN; ION CHANNEL; POTASSIUM ION; PROTEIN; RANOLAZINE; SLACK PROTEIN; SLICK PROTEIN; SODIUM ION; TETRODOTOXIN; UNCLASSIFIED DRUG; VERATRIDINE; ANTIDIABETIC AGENT; MESSENGER RNA; NERVE PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SLACK PROTEIN, RAT; SLICK PROTEIN, RAT; SODIUM; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; INSULIN RELEASE; LATE SODIUM CURRENT; LONG TERM EXPOSURE; NONHUMAN; NORMAL HUMAN; PANCREAS ISLET BETA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSAL POTENTIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM CURRENT; STEADY STATE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; MEMBRANE POTENTIAL; METABOLISM; SECRETION (PROCESS); TIME;

ANIMALS; CELL LINE; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MEMBRANE POTENTIALS; NERVE TISSUE PROTEINS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RNA, MESSENGER; SODIUM; TIME FACTORS; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84937813899     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-014-1613-0     Document Type: Article

References (51)

1. Aoki K, Kosakai K, Yoshino M (2008) Monoaminergic modulation of the Na+-activated K+ channel in Kenyon cells isolated from the mushroom body of the cricket (Gryllus bimaculatus) brain. J Neurophysiol 100:1211–1222
2. Bansal P, Wang Q (2008) Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 295:E751–E761
3. Barnett DW, Pressel DM, Misler S (1995) Voltage-dependent Na+ and Ca2+ currents in human pancreatic islet beta-cells: evidence for roles in the generation of action potentials and insulin secretion. Pflugers Arch 431:272–282
4. Belardinelli L, Shryock JC, Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92(Suppl 4):iv6–iv14
5. Bhattacharjee A, Gan L, Kaczmarek LK (2002) Localization of the Slack potassium channel in the rat central nervous system. J Comp Neurol 454:241–254
6. Bhattacharjee A, von Hehn CA, Mei X, Kaczmarek LK (2005) Localization of the Na+-activated K+ channel Slick in the rat central nervous system. J Comp Neurol 484:80–92
7. Braun M, Ramracheya R, Bengtsson M, Zhang Q, Karanauskaite J, Partridge C, Johnson PR, Rorsman P (2008) Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57:1618–1628
8. Budelli G, Hage TA, Wei A, Rojas P, Jong YJ, O’Malley K, Salkoff L (2009) Na+-activated K+ channels express a large delayed outward current in neurons during normal physiology. Nat Neurosci 12:745–750
9. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116:1449–1457
10. Catterall WA, Goldin AL, Waxman SG (2003) International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev 55:575–578
11. Chen WJ, Liu XY, Wang LX, Wang YP, Liu XH, Liu LB (2011) Oxidative damage to the endoplasmic reticulum stress pathway of apoptosis-related molecules expression in MIN6 cell. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27:249–252, 256
12. Dhalla AK, Yang M, Ning Y, Kahlig KM, Krause M, Rajamani S, Belardinelli L (2014) Blockade of Na+ channels in pancreatic alpha-cells has anti-diabetic effects. Diabetes. doi:10.2337/db13-1562
13. Donatsch P, Lowe DA, Richardson BP, Taylor P (1977) The functional significance of sodium channels in pancreatic beta-cell membranes. J Physiol 267:357–376
14. Eberhardson M, Grapengiesser E (1999) Role of voltage-dependent Na+ channels for rhythmic Ca2+ signalling in glucose-stimulated mouse pancreatic beta-cells. Cell Signal 11:343–348
15. Egan TM, Dagan D, Kupper J, Levitan IB (1992) Properties and rundown of sodium-activated potassium channels in rat olfactory bulb neurons. J Neurosci 12:1964–1976
16. Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM, Bers DM (2013) Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502:372–376
17. Fang YH, Piao L, Hong ZG, Toth PT, Marsboom G, Bache-Wiig P, Rehman J, Archer SL (2012) Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle. J Mol Med-JMM 90:31–43
18. Gao SB, Wu Y, Lu CX, Guo ZH, Li CH, Ding JP (2008) Slack and Slick KNa channels are required for the depolarizing afterpotential of acutely isolated, medium diameter rat dorsal root ganglion neurons. Acta Pharmacol Sin 29:899–905
19. Hage TA, Salkoff L (2012) Sodium-activated potassium channels are functionally coupled to persistent sodium currents. J Neurosci 32:2714–2721
20. Hatlapatka K, Willenborg M, Rustenbeck I (2009) Plasma membrane depolarization as a determinant of the first phase of insulin secretion. Am J Physiol Endocrinol Metab 297:E315–E322
21. Hirakawa R, El Bizri N, Shryock JC, Belardinelli L, Rajamani S (2012) Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine. Neuropharmacology 62:2251–2260
22. Huang YC, Rupnik MS, Karimian N, Herrera PL, Gilon P, Feng ZP, Gaisano HY (2013) In situ electrophysiological examination of pancreatic alpha cells in the streptozotocin-induced diabetes model, revealing the cellular basis of glucagon hypersecretion. Diabetes 62:519–530
23. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010:453892
24. Kim YC, Sim JH, Kang TM, Suzuki H, Kim SR, Kwon SC, Xu WX, Lee SJ, Kim KW (2007) Sodium-activated potassium current in guinea pig gastric myocytes. J Korean Med Sci 22:57–62
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408
26. Lu BX, Liu LY, Liao L, Zhang ZH, Mei YA (2005) Inhibition of Na+ channel currents in rat myoblasts by 4-aminopyridine. Toxicol Appl Pharmacol 207:275–282
27. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD (1996) Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93:135–142
28. Mei YA, Wu MM, Huan CL, Sun JT, Zhou HQ, Zhang ZH (2000) 4-Aminopyridine, a specific blocker of K(+) channels, inhibited inward Na(+) current in rat cerebellar granule cells. Brain Res 873:46–53
29. Meissner HP, Schmelz H (1974) Membrane potential of beta-cells in pancreatic islets. Pflugers Arch 351:195–206
30. Morrow DA, Scirica BM, Chaitman BR, McGuire DK, Murphy SA, Karwatowska-Prokopczuk E, McCabe CH, Braunwald E (2009) Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 119:2032–2039
31. Nesher R, Anteby E, Yedovizky M, Warwar N, Kaiser N, Cerasi E (2002) Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 51(Suppl 1):S68–S73
32. Ning Y, Zhen W, Fu Z, Jiang J, Liu D, Belardinelli L, Dhalla AK (2011) Ranolazine increases beta-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice. J Pharmacol Exp Ther 337:50–58
33. Pressel DM, Misler S (1990) Sodium channels contribute to action potential generation in canine and human pancreatic islet B cells. J Membr Biol 116:273–280
34. Qian C, Ma J, Zhang P, Luo A, Wang C, Ren Z, Kong L, Zhang S, Wang X, Wu Y (2012) Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes. PLoS One 7:e51358
35. Rajamani S, Shryock JC, Belardinelli L (2008) Block of tetrodotoxin-sensitive, Na(V)1.7 and tetrodotoxin-resistant, Na(V)1.8, Na+ channels by ranolazine. Channels (Austin) 2:449–460
36. Rajamani S, Shryock JC, Belardinelli L (2008) Rapid kinetic interactions of ranolazine with HERG K+ current. J Cardiovasc Pharmacol 51:581–589
37. Rosati B, Marchetti P, Crociani O, Lecchi M, Lupi R, Arcangeli A, Olivotto M, Wanke E (2000) Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J 14:2601–2610
38. Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L (2006) Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318:214–222
39. Stafstrom CE (2007) Persistent sodium current and its role in epilepsy. Epilepsy Curr 7:15–22
40. Undrovinas A, Maltsev VA (2008) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6:348–359
41. Undrovinas NA, Maltsev VA, Belardinelli L, Sabbah HN, Undrovinas A (2010) Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J Physiol Sci 60:245–257
42. Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, Maier SK, Zhang T, Hasenfuss G, Brown JH, Bers DM et al (2006) Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels. J Clin Invest 116:3127–3138
43. Wang GK, Calderon J, Wang SY (2008) State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Mol Pharmacol 73:940–948
44. Wang M, Crager M, Pugazhenthi S (2012) Modulation of apoptosis pathways by oxidative stress and autophagy in beta cells. Exp Diabetes Res 2012:647914
45. Wang Y, Gao L, Li Y, Chen H, Sun Z (2011) Nifedipine protects INS-1 beta-cell from high glucose-induced ER stress and apoptosis. Int J Mol Sci 12:7569–7580
46. Wang Z, Thurmond DC (2009) Mechanisms of biphasic insulin-granule exocytosis—roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci 122:893–903
47. Yang B, Desai R, Kaczmarek LK (2007) Slack and Slick K(Na) channels regulate the accuracy of timing of auditory neurons. J Neurosci 27:2617–2627
48. Yang B, Gribkoff VK, Pan J, Damagnez V, Dworetzky SI, Boissard CG, Bhattacharjee A, Yan Y, Sigworth FJ, Kaczmarek LK (2006) Pharmacological activation and inhibition of Slack (Slo2.2) channels. Neuropharmacology 51:896–906
49. Zaza A, Belardinelli L, Shryock JC (2008) Pathophysiology and pharmacology of the cardiac “late sodium current”. Pharmacol Ther 119:326–339
50. Zaza A, Rocchetti M (2013) The late Na+ current—origin and pathophysiological relevance. Cardiovasc Drugs Ther 27:61–68
51. Zhu HL, Wassall RD, Takai M, Morinaga H, Nomura M, Cunnane TC, Teramoto N (2009) Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na currents, Na1.6, in murine vas deferens myocytes. Br J Pharmacol 157:1483–1493